<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ralph D</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NIAMS NIH HHS</funding><pagination>e1010192</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9089899</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(4)</volume><pubmed_abstract>Pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI) are clinically distinct genetic entities of ectopic calcification associated with differentially reduced circulating levels of inorganic pyrophosphate (PPi), a potent endogenous inhibitor of calcification. Variants in ENPP1, the gene mutated in GACI, have not been associated with classic PXE. Here we report the clinical, laboratory, and molecular evaluations of ten GACI and two PXE patients from five and two unrelated families registered in GACI Global and PXE International databases, respectively. All patients were found to carry biallelic variants in ENPP1. Among ten ENPP1 variants, one homozygous variant demonstrated uniparental disomy inheritance. Functional assessment of five previously unreported </pubmed_abstract><journal>PLoS genetics</journal><pubmed_title>ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification.</pubmed_title><pmcid>PMC9089899</pmcid><funding_grant_id>R21 AR077332</funding_grant_id><funding_grant_id>R01 AR072695</funding_grant_id><funding_grant_id>R21AR077332</funding_grant_id><funding_grant_id>R01AR072695</funding_grant_id><pubmed_authors>Nitschke Y</pubmed_authors><pubmed_authors>Levine MA</pubmed_authors><pubmed_authors>Ralph D</pubmed_authors><pubmed_authors>Uitto J</pubmed_authors><pubmed_authors>Rutsch F</pubmed_authors><pubmed_authors>Terry SF</pubmed_authors><pubmed_authors>Wurst T</pubmed_authors><pubmed_authors>Youssefian L</pubmed_authors><pubmed_authors>Saeidian AH</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Caffet M</pubmed_authors><pubmed_authors>Vahidnezhad H</pubmed_authors></additional><is_claimable>false</is_claimable><name>ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification.</name><description>Pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI) are clinically distinct genetic entities of ectopic calcification associated with differentially reduced circulating levels of inorganic pyrophosphate (PPi), a potent endogenous inhibitor of calcification. Variants in ENPP1, the gene mutated in GACI, have not been associated with classic PXE. Here we report the clinical, laboratory, and molecular evaluations of ten GACI and two PXE patients from five and two unrelated families registered in GACI Global and PXE International databases, respectively. All patients were found to carry biallelic variants in ENPP1. Among ten ENPP1 variants, one homozygous variant demonstrated uniparental disomy inheritance. Functional assessment of five previously unreported </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-31T12:59:25.069Z</modification><creation>2025-04-06T21:51:00.322Z</creation></dates><accession>S-EPMC9089899</accession><cross_references><pubmed>35482848</pubmed><doi>10.1371/journal.pgen.1010192</doi></cross_references></HashMap>